Annual CFI
$47.19 M
+$165.43 M+139.92%
31 December 2022
Summary:
Rain Therapeutics annual cash flow from investing activities is currently $47.19 million, with the most recent change of +$165.43 million (+139.92%) on 31 December 2022. During the last 3 years, it has risen by +$52.38 million (+1009.15%).RAIN Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$4.24 M
-$15.35 M-78.38%
30 September 2023
Summary:
Rain Therapeutics quarterly cash flow from investing activities is currently $4.24 million, with the most recent change of -$15.35 million (-78.38%) on 30 September 2023.RAIN Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$10.15 M
-$7.39 M-42.14%
30 September 2023
Summary:
Rain Therapeutics TTM cash flow from investing activities is currently $10.15 million, with the most recent change of -$7.39 million (-42.14%) on 30 September 2023.RAIN TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RAIN Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +1009.1% | +104.6% | +107.3% |
| 5 y5 years | - | - | - |
RAIN Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | at high | -89.2% | -88.1% |
Rain Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $4.24 M(-78.4%) | $10.15 M(-42.1%) |
| June 2023 | - | $19.59 M(+456.8%) | $17.54 M(-52.9%) |
| Mar 2023 | - | $3.52 M(-120.5%) | $37.28 M(-21.0%) |
| Dec 2022 | $47.19 M(-139.9%) | -$17.19 M(-247.9%) | $47.19 M(-44.9%) |
| Sept 2022 | - | $11.63 M(-70.4%) | $85.63 M(-555.6%) |
| June 2022 | - | $39.32 M(+192.7%) | -$18.80 M(-82.1%) |
| Mar 2022 | - | $13.44 M(-36.8%) | -$104.77 M(-11.4%) |
| Dec 2021 | -$118.23 M | $21.25 M(-122.9%) | -$118.23 M(-15.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$92.80 M(+98.9%) | -$139.51 M(+169.0%) |
| June 2021 | - | -$46.65 M(>+9900.0%) | -$51.87 M(+893.7%) |
| Mar 2021 | - | -$29.00 K(-17.1%) | -$5.22 M(+0.6%) |
| Dec 2020 | -$5.19 M(+3504.9%) | -$35.00 K(-99.3%) | -$5.19 M(+0.7%) |
| Sept 2020 | - | -$5.16 M(<-9900.0%) | -$5.16 M(<-9900.0%) |
| June 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2020 | - | $0.00 | $0.00 |
| Dec 2019 | -$144.00 K | - | - |
FAQ
- What is Rain Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Rain Therapeutics?
- What is Rain Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Rain Therapeutics?
- What is Rain Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Rain Therapeutics?
What is Rain Therapeutics annual cash flow from investing activities?
The current annual CFI of RAIN is $47.19 M
What is the all time high annual CFI for Rain Therapeutics?
Rain Therapeutics all-time high annual cash flow from investing activities is $47.19 M
What is Rain Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of RAIN is $4.24 M
What is the all time high quarterly CFI for Rain Therapeutics?
Rain Therapeutics all-time high quarterly cash flow from investing activities is $39.32 M
What is Rain Therapeutics TTM cash flow from investing activities?
The current TTM CFI of RAIN is $10.15 M
What is the all time high TTM CFI for Rain Therapeutics?
Rain Therapeutics all-time high TTM cash flow from investing activities is $85.63 M